Agarwal S,Agrawal DK .2017 .Kawasaki disease: etiopathogenesis and novel treatment strategies. Expert. Rev. Clin. Immunol, 13(3) : 247-258.
Bordea MA,Costache C,Grama A,Florian AI,Lupan I,Samasca G,Deleanu D,Makovicky P,Makovicky P,Rimarova K P .2022 .Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome. Physiol. Res., 71(1) : 17-27.
Cheng F,Kang L,Zhang F,Ma H,Wang X,Dong Y,An H Y .2020 .Analysis of hyperbilirubinemia in patients with Kawasaki disease. Medicine (Baltimore), 99(36) : e21974.
Danieli MG,Antonelli E,Auria S,Buti E,Shoenfeld Y .2023 .Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions. Autoimmun., : .
Pak. J. Pharm. Sci. ,November -December .2025 .. , 22(11) : 103451-2086.
Duley L,Meher S,Hunter KE,Seidler AL,Askie LM .2019 .Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane. Database. Syst. Rev., 10 : CD004659.
Feng H,Chai H,Li D,Shi C,Xu Y,Liu Y Y .2024 .Expression of PCT, BNP and inflammatory factors in children with Kawasaki disease and their correlation with coronary artery lesions. Altern. Ther. Health Med, 30(1) : 302-306.
Florescu C,Mustafa ER,Tartea EA,Florescu DR,Albu VC .2019 .Antiplatelet therapy in secondary ischemic stroke prevention - a short review. Rom. J. Morphol. Embryol., 60(2) : 383-387.
Fukui S,Seki M,Minami T,Kotani K,Oka K,Yokomizo A,Matsubara D,Sato T,Nozaki Y,Saito M,Kikuchi Y,Miyamoto K,Monden Y,Yamagata T Y .2021 .Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: A randomized controlled trial. Pediatr. Rheumatol, 19(1) : 107.
Hamwi S,Alebaji MB,Mahboub AE,Alkaabi EH,Alkuwaiti NS .2023 .Multiple systemic arterial aneurysms in Kawasaki disease. Cureus, 15(7) : e42714.
Huang S,Liu L,Qian G,Liu W,Wang J,Li M,Yang G,Public G .2020 .The improvement effect of different doses of gamma globulin on the disease condition of infants with hemolytic disease of newborn and their effects on immune factors in serum. , 49(5) : 914-922.
Kamarova M,Baig S,Patel H,Monks K,Wasay M,Ali A,Redgrave J,Majid A,Bell SM .2022 .Antiplatelet use in ischemic stroke. , 56(10) : 1159-1173.
Kuo HC .2023 .. Progress and Treatment Update of Kawasaki Disease. Int. J. Mol. Sci, 24(18) : 13948.
Lee W,Cheah CS,Suhaini SA,Azidin AH,Khoo MS,Ismail NAS,Ali A .2022 .Clinical manifestations and laboratory findings of Kawasaki disease: Beyond the classic diagnostic features. Medicina (Kaunas, Lithuania), 58(6) : 734.
Li Y,Chen B Y .2023 .Gamma globulin combined with acyclovir for children with infectious mononucleosis and their effect on immune function. Am. J. Transl. Res., 15(6) : 4399-4407.
Liu E,Gonzalez J,Siu A .2021 .Use of premedication with intravenous immune globulin in Kawasaki disease: A retrospective review. Pediatr. Allergy. Immunol., 32(4) : 750-755.
Marchesi A,Tarissi de Jacobis I,Rigante D,Rimini A,Malorni W,Corsello G,Bossi G,Buonuomo S,Cardinale F,Cortis E,De Benedetti F,De Zorzi A,Duse M,Del Principe D,Dellepiane RM,D'Isanto L,El Hachem M,Esposito S,Falcini F,Giordano U,Maggio MC,Mannarino S,Marseglia G,Martino S,Marucci G,Massaro R,Pescosolido C,Pietraforte D,Pietrogrande MC,Salice P,Secinaro A,Straface E,Villani A .2018 .Kawasaki disease: Guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase. Ital. J. Pediatr., 44(1) : 102.
Noval Rivas M and Arditi M .2020 .Kawasaki disease: Pathophysiology and insights from mouse models. Nat. Rev. Rheumatol., 16(7) : 391-405.
Oda T,Nagata H,Nakashima Y,Nanishi E,Takada Y,Nishimura M,Kubo E,Hatae K,Ohga S K .2019 .Clinical utility of highly purified 10% liquid intravenous immunoglobulin in Kawasaki disease. J. Pediatr., 214 : 227-230.
Gedalia Rife E,A Rife E .2020 .. Kawasaki Disease: An Update. Curr. Rheumatol. Rep, 22(10) : 75.
Singh S,Vignesh P,Burgner D P .2015 .The epidemiology of Kawasaki disease: A global update. Arch. Dis. Child., 100(11) : 1084-1088.
Sun H,Lu H,Wu Y .2022 .Efficacy of gamma globulins in children with Kawasaki disease and factors influencing children's short-term prognosis. Comput. Math. Methods. Med, : 5137874.
Surianarayanan V,Hoather TJ,Tingle SJ,Thompson ER,Hanley J,Wilson CH .2021 .Interventions for preventing thrombosis in solid organ transplant recipients. Cochrane. Database. Syst. Rev., 3(3) : CD011557.
Tanoshima R,Hashimoto R,Suzuki T,Ishiguro A,Kobayashi T .2019 .Effectiveness of antiplatelet therapy for Kawasaki disease: A systematic review. Eur. J. Pediatr., 178(6) : 947-955.
Tawfik DS,Cowan KR,Walsh AM,Hamilton WS,Goldman FD .2012 .Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production. Pediatr Allergy Immunol, 23(1) : 88-95.
Wang L,He M,Wang W,Li S,Zhao G .2024 .Efficacy and safety of infliximab in the treatment of Kawasaki disease: A systematic review and meta-analysis. Eur. J. Pediatr., 183(4) : 1765-1776.
Wang Y,Li C,Niu L,Fu M,Tian J,An X .2021 .Difference in serum miRNA expression between immunoglobulin-sensitive and -insensitive incomplete Kawasaki disease patients. Exp. Ther. Med, 21(2) : 162.
Wang Z,Xie L,Ding G,Song S,Chen L,Li G,Xia M,Han D,Zheng Y,Liu J,Xiao T,Zhang H,Huang Y,Li Y,Huang M Y .2021 .Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients. Nat. Commun, 12(1) : 5444.
Xiong Y,Xu J,Zhang D,Wu S,Li Z,Zhang J,Xia Z,Xia P,Xia C,Tang X,Liu X,Liu J,Yu P .2022 .MicroRNAs in Kawasaki disease: An update on diagnosis, therapy and monitoring. Front. Immunol., 13 : 1016575.
Xu D,Feng CH,Cao AM,Yang S,Tang ZC,Li XH .2024 .Progression prediction of coronary artery lesions by echocardiography-based ultrasomics analysis in Kawasaki disease. Ital. J. Pediatr., 50(1) : 185.